Tamara Intermesoli

Mechanisms of Resistance to Targeted Therapies in Chronic Myeloid Leukemia.

F. Lussana, A. Rambaldi, Alessandro Rambaldi, 2018, Handbook of experimental pharmacology.

Ofatumumab Is More Efficient than Rituximab in Lysing B Chronic Lymphocytic Leukemia Cells in Whole Blood and in Combination with Chemotherapy

M. Introna, A. Rambaldi, Alessandro Rambaldi, 2013, The Journal of Immunology.